Evaluation of polar-embedded and polar-endcapped C12-C18 stationary phase vulnerabilities toward highly nucleophilic compounds: A case study

LC-GC North America

Volumn 23, Issue 8, 2005, Pages 762-765

  Burge, Larry J ^a   Sorgen, Christina M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27544498003     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. T. Tukamoto and S. Ozeki, Yakuzazaigaku 27(4), 336-339 (1967).
2. F.O. Lassen and C.H. Hammer, J. Org. Chem. 56(18), 2631-2634 (1971).
3. J.W. Lamb, Anal. Profiles Drug Subst. 1, 53-64 (1972).
4. H.L. El-Obeid and A.A. Al-Badr, Anal. Profiles Drug Subst. 18, 567-597 (1989).
5. D.G. Musson, S.M. Maglietto, S.S. Hwang, D. Gravellese, and W.F. Bayne, J. Chrom. 414, 121-129 (1987).
6. United States Pharmacopeia 25, National Formulary 20, (United States Pharmacopeial Convention, Inc., Rockville, Maryland, 2001).
7. Mac-Mod Technical Report, Number 00111TR.
8. Mac-Mod HPLC Columns Product Bulletin, Number 000401PB.
9. Mac-Mod HPLC Lab Notes, "When to Use a Polar Embedded Phase Column," Sept. 4, 2001.
10. P. Ross, I.D. DeGraff, and R.A. Henry, "A Comparative Study of HPLC Stationary Phases with Unique Polar Selectivity," Thermo Hypersil-Keystone Scientific Operations technical publication (Thermo Electron, Waltham, Massachusetts).
11. J. Layne, J. Chrom. 957(2), 149-164 (2002).
12. U.D. Neue, Am. Lab. 33(18), 49-50 (2001).
13. L.R. Snyder, J.J. Kirkland, and J.L. Glajch, in Practical HPLC Method Development, 2nd ed. (John Wiley & Sons, Hoboken, New Jersey, 1997), pp. 317-321.